XML 31 R18.htm IDEA: XBRL DOCUMENT
v3.24.0.1

BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES (Tables) | 3 Months Ended
--- | ---
Dec. 31, 2023
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES |
Schedule of revenues disaggregated by business operations and timing of revenue recognition | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Month Period Ended:
​ | ​ | December 31, | ​ | December 31,
​ |  | 2023 |  | 2022
Research and development services (over-time) | ​ | $ | 77,535 | ​ | $ | 126,058
Clinical laboratory testing services (point-in-time) | ​ | ​ | 12,120 | ​ | ​ | 3,074,414
Clinical laboratory testing services (over-time) | ​ | ​ | 324,580 | ​ | ​ | 1,439,881
Product and authentication services (point-in-time): | ​ |  | ​ | ​ |  | ​
Supply chain | ​ |  | 467,487 | ​ |  | 411,765
Large Scale DNA Production | ​ | ​ | — | ​ | ​ | 127,506
Asset marking | ​ |  | 9,442 | ​ |  | 83,128
Total | ​ | $ | 891,164 | ​ | $ | 5,262,752
Schedule of opening and closing contract balances | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | October 1, | ​ | December 31, | ​ | $
​ |  | Balance sheet classification |  | 2023 |  | 2023 |  | change
Contract liabilities |  | Deferred revenue | ​ | $ | 270,435 | ​ | $ | 282,034 | ​ | $ | 11,599
Schedule of anti-dilutive securities not included computation of net loss per share | Securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share because to do so would have been anti-dilutive for the three-month periods ended December 31, 2023 and 2022 are as follows: ​
​ | ​ | ​ | ​ | ​
​ |  | 2023 |  | 2022
Warrants | ​ | 5,213,213 | ​ | 7,295,588
Restricted Stock Units | ​ | 282,640 | ​ | —
Stock options | ​ | 2,189,019 | ​ | 1,006,141
Total | ​ | 7,684,872 | ​ | 8,301,729

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration